P-001
Chronic Lymphocytic Leukemia
Phase 2Active
Key Facts
About Panacea Biotec
India‑based pharma delivering generics, biosimilars, and novel oncology drugs with a strong formulation platform.
View full company profileTherapeutic Areas
Other Chronic Lymphocytic Leukemia Drugs
| Drug | Company | Phase |
|---|---|---|
| Dual Force Immunotherapy for CLL | ViferaXS | Phase 2 |
| clonoSEQ (CLL, Blood/BM) | Adaptive Biotechnologies | FDA-Cleared |